CXCR4 and kidney disorder: In an adriamycin (ADR)-induced nephropathy model, increased CXCR4 expression was found to be associated with podocyte injury, and blockade of this pathway reduced podocyte oxidative stress, proteinuria, and fibrosis (Mo et al., 2022).